Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Miami, Florida 33136


Purpose:

Comparison of outcomes/safety/and tolerability of SRL/FK/Pred vs. FK/MMF/Pred vs. SRL/Neoral®/Pred in cadaveric and non-HLA identical LRD kidney transplants.


Criteria:

Inclusion Criteria: - Age >14 years - Weight > 40 kg - Primary renal allograft: cadaveric or mismatched living donor - Negative standard cross match for T-cells - Women of childbearing potential will be required to have a negative qualitative serum pregnancy test and agree to use an adequate method of contraception throughout the study period and for 3 months after discontinuation of study medication (3yrs, 3 mos.) - Signed and dated informed consent (Parent or legal guardian must provide written consent for patients <18 years of age) Exclusion Criteria: - Evidence of systemic infection - History of malignancy within 10 years (with the exception of localized skin cancer) - Use of any investigational drug or treatment up to 4 weeks prior to enrolling in the study and during the 12-month treatment phase - Concurrent use of astemizole, pimozide, cisapride, terfenadine, or ketoconazole - Known hypersensitivity to sirolimus and its derivatives - Patients with a screening/baseline (or within 96 hours of transplant) - total white blood cell count < 4000/mm3; - platelet count < 100,000/mm3; - fasting triglycerides > 400 mg/dl (> 4.6 mmol/L); - fasting total cholesterol > 300 mg/dl (> 7.8 mmol/L); - fasting HDL-cholesterol < 30 mg/dl; - fasting LDL-cholesterol > 200mg/dl


NCT ID:

NCT00681213


Primary Contact:

N/A


Backup Contact:

N/A


Location Contact:

Miami, Florida 33136
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: January 16, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.